Research & Development

ChemRoutes Corporation, as part of its mission to make drug discovery affordable for its global client base in industry (pharmaceutical, agrochemical and biotech), research institutes and academia has introduced a novel portfolio of research products under the ChemDiscovery Platform™.  These target areas of GPCR, Kinase, Ion channels and Nuclear hormone receptor based research.

Its employees, recruited from all over the world, have graduate school and post-doctoral scientific training at universities in Europe, Asia, and N. America. Its purpose built chemistry facilities include state of the art synthesis and analysis equipment and technologies. All personnel are WHIMS trained and compliant.

The product portfolio includes novel building blocks and templates available exclusively through its catalog offering. Custom modifications are also available. All products are shipped with Certificate of Analysis and MSDS documentation and are guaranteed at > 95% purity.

In order to improve the hit rates during screening, recent product offering additions include focussed libraries of small molecules to enhance internal compound collections of its industrial partners, while simultaneously increasing the availability of screening compounds available for its academic partners.